Letter: sorafenib in portal hypertension – authors' reply

Authors

  • M. Peck-Radosavljevic,

    1. Vienna HCC Study Group, Division of Gastroenterology & Hepatology, Medical University of Vienna, Vienna, Austria
    2. Vienna Hepatic Hemodynamic Laboratory, Division of Gastroenterology & Hepatology, Medical University of Vienna, Vienna, Austria
    3. Internal Medicine III, Division of Gastroenterology & Hepatology, Medical University of Vienna, Vienna, Austria
    Search for more papers by this author
  • M. Pinter,

    1. Vienna HCC Study Group, Division of Gastroenterology & Hepatology, Medical University of Vienna, Vienna, Austria
    2. Internal Medicine III, Division of Gastroenterology & Hepatology, Medical University of Vienna, Vienna, Austria
    Search for more papers by this author
  • T. Reiberger,

    1. Vienna Hepatic Hemodynamic Laboratory, Division of Gastroenterology & Hepatology, Medical University of Vienna, Vienna, Austria
    2. Internal Medicine III, Division of Gastroenterology & Hepatology, Medical University of Vienna, Vienna, Austria
    Search for more papers by this author
  • A. Ferlitsch,

    1. Vienna Hepatic Hemodynamic Laboratory, Division of Gastroenterology & Hepatology, Medical University of Vienna, Vienna, Austria
    2. Internal Medicine III, Division of Gastroenterology & Hepatology, Medical University of Vienna, Vienna, Austria
    Search for more papers by this author
  • W. Sieghart

    1. Vienna HCC Study Group, Division of Gastroenterology & Hepatology, Medical University of Vienna, Vienna, Austria
    2. Internal Medicine III, Division of Gastroenterology & Hepatology, Medical University of Vienna, Vienna, Austria
    Search for more papers by this author

No abstract is available for this article.

Ancillary